Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Andrew D . Badley, M.D.

Back to Research Profile

  1. Cummins N, Badley A. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med 2009 May; 9(4):495-505.
    View PubMed
  2. Singh VP, Bren GD, Algeciras-Schimnich A, Schnepple D, Navina S, Rizza SA, Dawra RK, Saluja AK, Chari ST, Vege SS, Badley AD. Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol 2009 May; 296(5):G1040-6. Epub 2009 Mar 12.
    View PubMed
  3. O'Hara SP, Small AJ, Gajdos GB, Badley AD, Chen XM, Larusso NF. HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J Infect Dis 2009 Apr 15; 199(8):1195-204.
    View PubMed
  4. Trushin SA, Bren GD, Badley AD. CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype. Open Virol J 2009; 3:21-5. Epub 2009 Apr 01.
    View PubMed
  5. Babu CK, Suwansrinon K, Bren GD, Badley AD, Rizza SA. HIV induces TRAIL sensitivity in hepatocytes. PLoS One 2009; 4(2):e4623. Epub 2009 Feb 27.
    View PubMed
  6. Bren GD, Trushin SA, Whitman J, Shepard B, Badley AD. HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8. PLoS One 2009; 4(3):e4875. Epub 2009 Mar 16.
    View PubMed
  7. van de Beek D, Patel R, Campeau NG, Badley A, Parisi JE, Rabinstein AA, Manno EM, Wijdicks EF. Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients. Neurology 2008 Jun 10; 70(24 Pt 2):2411-3.
    View PubMed
  8. Shepard BD, Loutfy MR, Raboud J, Mandy F, Kovacs CM, Diong C, Bergeron M, Govan V, Rizza SA, Angel JB, Badley AD. Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. J Acquir Immune Defic Syndr 2008 Jun 1; 48(2):149-55.
    View PubMed
  9. Hisatomi T, Nakazawa T, Noda K, Almulki L, Miyahara S, Nakao S, Ito Y, She H, Kohno R, Michaud N, Ishibashi T, Hafezi-Moghadam A, Badley AD, Kroemer G, Miller JW. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest 2008 Jun; 118(6):2025-38.
    View PubMed
  10. Rizza SA, Badley AD. HIV protease inhibitors impact on apoptosis. Med Chem 2008 Jan; 4(1):75-9.
    View PubMed
  11. Shepard BD, De Forni D, McNamara DR, Foli A, Rizza SA, Abraham RS, Knutson K, Wettstein PJ, Lori F, Badley AD. Beneficial effect of TRAIL on HIV burden, without detectable immune consequences. PLoS One 2008; 3(8):e3096. Epub 2008 Aug 28.
    View PubMed
  12. Nie Z, Bren GD, Rizza SA, Badley AD. HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells. Open Virol J 2008; 2:1-7.
    View PubMed
  13. Bren GD, Whitman J, Cummins N, Shepard B, Rizza SA, Trushin SA, Badley AD. Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS One 2008; 3(5):e2112. Epub 2008 May 07.
    View PubMed
  14. Rizza SR, Tangalos EG, McClees MD, Strausbauch MA, Targonski PV, McKean DJ, Wettstein PJ, Badley AD. Nelfinavir monotherapy increases naive T-cell numbers in HIV-negative healthy young adults. Front Biosci 2008; 13:1605-9. Epub 2008 Jan 01.
    View PubMed
  15. Vlahakis SR, Bren GD, Algeciras-Schimnich A, Trushin SA, Schnepple DJ, Badley AD. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival. Clin Pharmacol Ther 2007 Sep; 82(3):294-9 Epub 2007 Mar 14.
    View PubMed
  16. Nie Z, Bren GD, Vlahakis SR, Schimnich AA, Brenchley JM, Trushin SA, Warren S, Schnepple DJ, Kovacs CM, Loutfy MR, Douek DC, Badley AD. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol 2007 Jul; 81(13):6947-56 Epub 2007 Apr 18.
    View PubMed
  17. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 2007 Jun; 170(6):1820-30.
    View PubMed
  18. Vlahakis SR, Bennett SAL, Whitehead SN, Badley AD. HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo. Apoptosis 2007 May; 12(5):969-77.
    View PubMed
  19. Trushin SA, Algeciras-Schimnich A, Vlahakis SR, Bren GD, Warren S, Schnepple DJ, Badley AD. Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. J Immunol 2007 Apr 15; 178(8):4846-53.
    View PubMed
  20. O'Hara SP, Small AJ, Nelson JB, Badley AD, Chen XM, Gores GJ, Larusso NF. The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun 2007 Feb; 75(2):684-96.
    View PubMed
  21. Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 2007 Feb; 292(2):F837-44.
    View PubMed
  22. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl 2006 Aug; 12(8):1290-2.
    View PubMed
  23. Chui C, Cheung PK, Brumme CJ, Mo T, Brumme ZL, Montaner JS, Badley AD, Harrigan PR. HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2006 Jul; 22(7):615-8.
    View PubMed
  24. Vlahakis SR, Badley AD. Influence of proteasome inhibitors on apoptosis. Curr Opin Clin Nutr Metab Care 2006 Jan; 9(1):42-7.
    View PubMed
  25. Silvestri G, Lori F, Foli A, Montaner LJ, Clotet B, Barreiro P, Gatell JM, Poli G, Lederman M, Perno CF, Wainberg MA, Lieberman J, Bentwitch Z, Cooper DA, Badley A, Kinloch S, Miller S, Youle M, Autran B, Lisziewicz J, Weiner DB, Ensoli B, Franchini G, Introduction. J Acquir Immune Defic Syndr 2006; 42(3 SUPPL. 1):S1-S27.
    View PubMed
  26. Graham DB, Bell MP, Huntoon CJ, Weaver JGR, Hawley N, Badley AD, McKean DJ. Increased thymic output in HIV-negative patients after antiretroviral therapy. AIDS 2005 Sep 23; 19(14):1467-72.
  27. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, Badley AD, Caplice NM, Griffin MD, Nath KA. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int 2005 Aug; 68(2):611-22.
    View PubMed
  28. Badley AD. In vitro and in vivo effects of HIV protease inhibitors on apoptosis. Cell Death & Differentiation 2005 Aug; 12(Suppl 1):924-31.
    View PubMed
  29. Trushin SA, Bren GD, Asin S, Pennington KN, Paya CV, Badley AD. Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta. J Virol 2005 Aug; 79(15):9821-30.
    View PubMed
  30. Lum JJ, Schnepple DJ, Badley AD. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions. AIDS 2005 Jul 22; 19(11):1125-33.
    View PubMed
  31. Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophils by TNF-related apoptosis-inducing ligand. Journal of Immunology 2005 Jul 15; 175(2):1232-8.
    View PubMed
  32. Weaver JGR, Tarze A, Moffat TC, LeBras M, Deniaud A, Brenner C, Bren GD, Morin MY, Phenix BN, Dong L, Jiang SX, Sim VL, Zurakowski B, Lallier J, Hardin H, Wettstein P, van Heeswijk RPG, Douen A, Kroemer RT, Hou ST, Bennett SAL, Lynch DH, Kroemer G, Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J Clin Invest 2005 Jul; 115(7):1828-38.
    View PubMed
  33. Weaver JGR, McGregor CGA, Tazelaar HD, Badley AD. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. J Heart Lung Transplant 2005 Jul; 24(7):841-7.
  34. Anson BD, Weaver JGR, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005 Feb 19; 365(9460):682-6.
    View PubMed
  35. Cuerrier D, Nie Z, Badley AD, Davies PL. Ritonavir does not inhibit calpain in vitro. Biochemical & Biophysical Research Communications 2005 Feb 4; 327(1):208-11.
    View PubMed
  36. Weaver JGR, Rouse MS, Steckelberg JM, Badley AD. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J 2004 Aug; 18(11):1185-91.
    View PubMed
  37. Buenz EJ, Badley AD. Impact of mitochondrial regulation of apoptosis on the pathogenesis and treatment of HIV-1-induced immunodeficiency. Mitochondrion 2004 Jul; 4(2-3):235-54.
    View PubMed
  38. Lum JJ, Schnepple DJ, Nie ZL, Sanchez-Dardon J, Mbisa GL, Mihowich J, Hawley N, Narayan S, Kim JE, Lynch DH, Badley AD. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 2004 Jun; 78(11):6033-42.
    View PubMed
  39. Zhang XP, Lalezari JP, Badley AD, Dorr A, Kolis SJ, Kinchelow T, Patel IH. Assessment of drug-drug interaction potential of enfuvirtide in human immunodeficiency virus type 1-infected patients. Clinical Pharmacology & Therapeutics 2004 Jun; 75(6):558-68.
    View PubMed
  40. Owen C, Kazim F, Badley AD. Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression: a meta-analysis. AIDS 2004 Mar 5; 18(4):693-5.
    View PubMed
  41. Cooper CL, Phenix B, Mbisa G, Lum JJ, Parato K, Hawley N, Angel JB, Badley AD. Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. Front Biosci 2004 Jan; 9:338-41.
    View PubMed
  42. Buenz EJ, Weaver JG, Bauer BA, Chalpin SD, Badley AD. Cordyceps sinensis extracts do not prevent Fas-receptor and hydrogen peroxide-induced T-cell apoptosis. J Ethnopharmacol 2004 Jan; 90(1):57-62.
    View PubMed
  43. Lum JJ, Badley AD. Resistance to apoptosis: Mechanism for the development of HIV reservoirs. Current HIV Research 2003 Jul; 1(3):261-74.
    View PubMed
  44. Badley AD, Roumier T, Lum JJ, Kroemer G. Mitochondrion-mediated apoptosis in HIV-1 infection. Trends Pharmacol Sci 2003 Jun; 24(6):298-305.
    View PubMed
  45. Narayan S, Hawley N, Giguere P, Badley AD. Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitors. HIV Clinical Trials 2003 May-Jun; 4(3):164-9.
    View PubMed
  46. Lum JJ, Cohen OJ, Nie ZL, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen ZX, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 2003 May; 111(10):1547-54.
    View PubMed
  47. Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death & Differentiation 2002 Nov; 9(11):1172-84.
    View PubMed
  48. Phenix BN, Cooper C, Owen C, Badley AD. Modulation of apoptosis by HIV protease inhibitors. Apoptosis 2002 Aug; 7(4):295-312.
    View PubMed
  49. Pilon AA, Lum JJ, Sanchez-Dardon J, Phenix BN, Douglas R, Badley AD. Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor. Antimicrobial Agents & Chemotherapy 2002 Aug; 46(8):2687-91.
    View PubMed
  50. Phenix BN, Badley AD. Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection. Biochimie 2002 Feb; 84(2-3):251-64.
    View PubMed
  51. Parato KG, Kumar A, Badley AD, Sanchez-Dardon J, Chambers KA, Young CD, Lim WT, Kravcik S, Cameron DW, Angel JB. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of interleukin-10. AIDS 2002; 16(9):1251-6.
    View PubMed
  52. Hawley-Foss N, Mbisa G, Lum JJ, Pilon AA, Angel JB, Garber G, Badley AD. Effect of therapy cessation during a discordant response to highly active antiretroviral therapy: implications for scheduled therapeutic interruptions. Clin Infect Dis 2002; 34:553-6.
    View PubMed
  53. Mikhael J, Humphrey S, Jabi M, Badley AD. Atypical cause of pulmonary infiltrate in a typical patient. Can J Infect Dis 2002; 13:71-2.
  54. Cooper CL, Badley AD, Angel JB. Characteristics of hepatitis C virus infection in HIV-infected people. Can J Infect Dis 2001 May; 12(3):157-63.
    View PubMed
  55. Angel JB, Parato KG, Kumar A, Kravcik S, Badley AD, Fex C, Ashby D, Sun E, Cameron WD. Progressive human immunodeficiency virus specific immune recovery with prolonged viral suppression. J Inf Dis 2001; 183:546-54.
  56. Lum JJ, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, Mihowich J, Jamison K, Hawley-Foss N, Lynch DH, Badley AD. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2L. J Virol 2001; 75:11128-36.
    View PubMed
  57. Kravcik S, Magill A, Sanghvi B, Ogden R, Cameron DW, Lewis R, Yu G, Badley AD. Comparative CD4 T cell responses of protease inhibitor containing and sparing antiretroviral regimes. HIV Clinical Trials 2001; 2:160-70.
    View PubMed
  58. Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek D, Mbisa G, Deeks S, Harris JM, Barbour JD, Gross BH, Fracis IR, Halvorsen R, Asaad R, Lederman MM. Poor CD4+ T-cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001; 15:1749-56.
    View PubMed
  59. Hawley-Foss N, Mbisa G, Lum JJ, Pilon AA, Angel JB, Garber G, Badley AD. Effect of therapy cessation during a discordant response to highly active antiretroviral therapy: implications for scheduled therapeutic interruptions. Clin Infect Dis 2001; 33:344-8.
    View PubMed
  60. Phenix B, Lum JJ, Nie A, Sanchez-Dardon J, Badley AD. Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood 2001; 98:1078-85.
    View PubMed
  61. Giguere P, Badley AD. Issues concerning therapy with HIV protease inhibitors. Clinical Perspectives in HIV Therapy. The Medicine Group Ltd 2001:1-18.
  62. Kim WR, Badley AD, Wiesner RH, Porayko MK, Seaberg EC, Keating MR, Evans RW, Dickson ER, Krom RA, Paya CV. The economic impact of cytomegalovirus infection after liver transplantation. Transplantation 2000 Feb 15; 69(3):357-61.
    View PubMed
  63. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV associated lymphocyte apoptosis. Blood 2000; 96:2951-64.
    View PubMed
  64. Khaliq Y, Gallicano K, Leger R, Foster B, Badley A. A drug interaction between fusidic acid and a combination of ritonavir and saquinavir. Br J Clin Pharmacol 2000; 50:81-3.
    View PubMed
  65. Khaliq Y, Gallicano K, Seguin I, Fyke K, Carignan G, Bulman D, Badley A, Cameron DW. Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease. Br J Clin Pharmacol 2000; 50:108-15.
    View PubMed
  66. Lauzon W, Sanchez Dardon J, Cameron DW, Badley AD. Flow cytometric measurement of telomere length. Cytometry 2000; 42:159-64.
    View PubMed
  67. Phenix BN, Angel J, Mandy F, Parato K, Chambers KA, Kravcik S, Hawley-Foss N, Cassol S, Cameron DW, Badley AD. Decreased HIV associated T cell apoptosis by HIV protease inhibitors. AIDS Res & Hum Retro 2000; 6:559-67.
  68. Dockrell DH, Badley AD, Algeciras-Schimnich A, Simpson M, Schut R, Lynch DH, Paya CV. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Res Hum Retroviruses 1999 Nov 20; 15(17):1509-18.
    View PubMed
  69. Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. JAIDS 1999; 21:371-5.
    View PubMed
  70. Kravcik S, Victor G, Angel JB, Badley AD, Garber GE, Cameron DW. Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy. Clin Inf Dis 1999; 29:702-3.
  71. Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB. Dynamic correlation of apoptosis and Immune activation during treatment of HIV infection. Cell Death and Differentiation 1999; 6:420-32.
    View PubMed
  72. Hunt RH, Fallone CA, Badley AD, Thomson ABR. For the Canadian Helicobacter Study Group (CHSG). Update to the Canadian Consensus Conference on Helicobacter pylori infections in adults Can J Gastroenterol 1999; 13:213-7.
  73. Falagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R, Griffith J, Freeman R, Rohrer R, Werner BG, Snydman DR. Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. Transplantation 1998 Oct 27; 66(8):1020-8.
    View PubMed
  74. O'Connor WJ, Badley AD, Dicken CH, Murphy GM. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C. Mayo Clin Proc 1998 Sep; 73(9):895-7.
    View PubMed
  75. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 1998 Jul 1; 102(1):79-87.
    View PubMed
  76. Dockrell DH, Badley AD, Villacian JS, Heppelmann CJ, Algeciras A, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ, Paya CV. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest 1998 Jun 1; 101(11):2394-405.
    View PubMed
  77. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV. Transcriptional regulation of the human FasL promoter-enhancer region. J Biol Chem 1998 Feb 20; 273(8):4416-23.
    View PubMed
  78. Dockrell DH, Badley AD, Heppelmann CJ, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ, Paya CV. The Regulation of Fas Ligand Expression in Human Macrophages. J Clin Invest 1998; 101:2394-405.
    View PubMed
  79. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, Ilstrup DM, Wiesner RH, Krom RA, Smith TF, Paya CV. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997 Nov; 176(5):1135-40.
    View PubMed
  80. Badley AD, Seaberg EC, Porayko MK, Wiesner RH, Keating MR, Wilhelm MP, Walker RC, Patel R, Marshall WF, DeBernardi M, Zetterman R, Steers JL, Paya CV. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database. Transplantation 1997 Jul 15; 64(1):66-73.
    View PubMed
  81. Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997 Jan 6; 185(1):55-64.
    View PubMed
  82. Badley AD, Dockrell D, Paya CV. Apoptosis in AIDS. Adv Pharmacol 1997; 41:271-94.
  83. Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 1997; 48:25-33.
    View PubMed
  84. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstrup DM, Keating MR, Wiesner RH, Krom RA, Paya CV. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996 Oct 15; 62(7):926-34.
    View PubMed
  85. Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, Ilstrup DM, Wiesner RH, de Groen P, Walker RC, Paya CV. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. Liver Transpl Surg 1996 Sep; 2(5):375-82.
    View PubMed
  86. Badley AD, Steckelberg JM, Wollan PC, Thompson RL. Infectious rates of central venous pressure catheters: comparison between newly placed catheters and those that have been changed. Mayo Clin Proc 1996 Sep; 71(9):838-46.
    View PubMed
  87. Badley AD, van Scoy RE. Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole. Clin Infect Dis 1996 Aug; 23(2):394-5.
    View PubMed
  88. Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, Steers JL, Krom RA, Portela D, Cockerill FR, Paya CV. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996 Apr 27; 61(8):1192-7.
    View PubMed
  89. Badley AD, Patel R, Portela DF, Harmsen WS, Smith TF, Ilstrup DM, Steers JL, Wiesner RH, Paya CV. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients. J Infect Dis 1996 Feb; 173(2):446-9.
    View PubMed
  90. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996 Jan; 70(1):199-206.
    View PubMed
  91. Lynch DH, Campbell KA, Miller RE, Badley AD, Paya CV. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease Behring Inst Mitt , 1996; 97:1-10.
  92. MacMorran WS, Badley AD, Wilson WR. 26-year-old man with HIV infection and abdominal pain. Mayo Clin Proc 1995 Sep; 70(9):885-8.
    View PubMed
  93. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun 1993 Jun; 14(6):485-9.
    View PubMed
  94. Schlech W, Chase DP, Badley AD. A model of food-borne Listeria monocytogenes infection in the Sprague Dauley rat using gastric innoculation; development and effect of gastric acidity on infective dose. Int J Food Microbiology 1993; 18(1):15-24.
  95. Badley AD, MacCormick RE, LeBrun GP. Neoplastic imitators of small bowel Crohn's disease. Can J Gastroenterol 1992; 6(2):77-83.
  96. Badley AD, Phillips B, Haldane D, Dalton M. Pathogenic marine Vibrio species in selected Nova Scotian recreational coastal waters. Can J Pub Health 1990; 81:263-7.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.